BSPM [Biostar Pharmaceuticals,] SC 13D/A: 1 Name of Reporting Person Andrew Barron Worden

[1 Name of Reporting Person Andrew Barron Worden I.R.S. Identification No. of Above Person 2 Check the Appropriate Box if a Member of a Group (a) [ ] (b) [ ] 3 SEC Use Only 4 Source of Funds PF Items 2(d) or 2(e) [ ] 6 Citizenship or Place of Organization Number of 7 Sole Voting Power Shares Owned]

By | 2016-03-03T15:08:57+00:00 December 29th, 2009|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] SC 13D/A: (Original Filing)

[SCHEDULE 13D/A (Amendment No 2) Biostar Pharmaceuticals, (Name of Issuer)mmon Stock (Title of Class of Securities) 090678103 (CUSIP Number) Rebecca Baum 730 FIFTH AVENUE, 25TH FLOOR NEW YORK, NY 10019 212-359-0204 (Name,dress and Telephone Number of Person Authorized to Receive Notices andmmunications) December 16, 2009 (Date of Event which Requires Filing of this Statement) If]

By | 2016-02-07T17:49:29+00:00 December 29th, 2009|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] SC 13D/A: SCHEDULE 13D/A (Amendment No 2) Biostar Pharmaceuticals, (Name

[SCHEDULE 13D/A (Amendment No 2) Biostar Pharmaceuticals, (Name of Issuer)mmon Stock (Title of Class of Securities) 090678103 (CUSIP Number) Rebecca Baum 730 FIFTH AVENUE, 25TH FLOOR NEW YORK, NY 10019 212-359-0204 (Name,dress and Telephone Number of Person Authorized to Receive Notices andmmunications) December 16, 2009 (Date of Event which Requires Filing of this Statement) If]

By | 2016-02-07T17:50:27+00:00 December 29th, 2009|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] S-3: (Original Filing)

[Zhilin Li President and Chief Executive Officer 2nd Floor, No. 17, Jinpan Road, Haikou, Hainan Province, China 570216 0086-898-66811730 (Name, Address, including zip code, and Telephone Number, including area code, of Agent for Service) With a copy to: Charles Law, Esq. King & Wood LLP 125 S. Market Street, Suite 1175, San Jose, CA 95113 Telephone: 1408 - 947-1960; 0086-10-58785023] [EX-4.1 2 cphs3ex41122209.htm] [December 28, 2009 China Pharma Holdings, Inc. Second Floor, No. 17, Jinpan Road, Haikou, Hainan Province, China RE: China Pharma Holdings, Inc. Form S-3 Registration Statement (File No. 333- ) Dear Sir or Madam: Based upon the foregoing, and subject to the assumptions stated herein, we are of the opinion that: 1 The opinions herein are also subject to the] [H ANSEN B ARNETT & M AXWELL , P.C. A Professional Corporation CERTIFIED PUBLIC ACCOUNTANTS 5 Triad Center, Suite 750 www.hbmcpas.com Registered with the Public Company Accounting Oversight Board To the Board of Directors and the Shareholders China Pharma Holdings, Inc. As an independent registered public accounting firm, we hereby consent to the incorporation by reference in this Registration Statement]

By | 2016-03-03T21:20:20+00:00 December 28th, 2009|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] S-3: Zhilin Li President and Chief Executive Officer 2nd

[Zhilin Li President and Chief Executive Officer 2nd Floor, No. 17, Jinpan Road, Haikou, Hainan Province, China 570216 0086-898-66811730 (Name, Address, including zip code, and Telephone Number, including area code, of Agent for Service) With a copy to: Charles Law, Esq. King & Wood LLP 125 S. Market Street, Suite 1175, San Jose, CA 95113 Telephone: 1408 - 947-1960; 0086-10-58785023] [EX-4.1 2 cphs3ex41122209.htm] [December 28, 2009 China Pharma Holdings, Inc. Second Floor, No. 17, Jinpan Road, Haikou, Hainan Province, China RE: China Pharma Holdings, Inc. Form S-3 Registration Statement (File No. 333- ) Dear Sir or Madam: Based upon the foregoing, and subject to the assumptions stated herein, we are of the opinion that: 1 The opinions herein are also subject to the] [H ANSEN B ARNETT & M AXWELL , P.C. A Professional Corporation CERTIFIED PUBLIC ACCOUNTANTS 5 Triad Center, Suite 750 www.hbmcpas.com Registered with the Public Company Accounting Oversight Board To the Board of Directors and the Shareholders China Pharma Holdings, Inc. As an independent registered public accounting firm, we hereby consent to the incorporation by reference in this Registration Statement]

By | 2016-03-03T21:21:23+00:00 December 28th, 2009|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] S-3: (Original Filing)

[Zhilin Li President and Chief Executive Officer 2nd Floor, No. 17, Jinpan Road, Haikou, Hainan Province, China 570216 0086-898-66811730 (Name,dress,luding zipde, and Telephone Number,luding areade, ofent for Service) With apy to: Charles Law, Esq. King & Wood 125 S. Market Street, Suite 1175,] [cphs3ex41122209.htm 2 EX-4.1] [December 28, 2009 China Pharmas, Second Floor, No. 17, Jinpan Road, Haikou, Hainan Province, China RE: China Pharmas, Form S-3 Registration Statement (File No. 333- ) Dear Sir or Madam: Based upon the foregoing, and subject to thesumptions stated herein, we are of the opinion that:] [HEN B ARNETT & M AXWELL , P.C. A Professionalrporation CERTIFIED PUBLIC ACCOUNTANTS 5 Triad Center, Suite 750 www.hbmcpas.com Registered with the Publicmpany Accounting Oversight Board To the Board of Directors and the Shareholders China Pharmas, an independent registered public accounting firm, we herebynsent to theorporation by reference in this Registration Statement on Form S-3]

By | 2016-02-07T23:58:21+00:00 December 28th, 2009|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] S-3: Zhilin Li President and Chief Executive Officer 2nd

[Zhilin Li President and Chief Executive Officer 2nd Floor, No. 17, Jinpan Road, Haikou, Hainan Province, China 570216 0086-898-66811730 (Name,dress,luding zipde, and Telephone Number,luding areade, ofent for Service) With apy to: Charles Law, Esq. King & Wood 125 S. Market Street, Suite 1175,] [cphs3ex41122209.htm 2 EX-4.1] [December 28, 2009 China Pharmas, Second Floor, No. 17, Jinpan Road, Haikou, Hainan Province, China RE: China Pharmas, Form S-3 Registration Statement (File No. 333- ) Dear Sir or Madam: Based upon the foregoing, and subject to thesumptions stated herein, we are of the opinion that:] [HEN B ARNETT & M AXWELL , P.C. A Professionalrporation CERTIFIED PUBLIC ACCOUNTANTS 5 Triad Center, Suite 750 www.hbmcpas.com Registered with the Publicmpany Accounting Oversight Board To the Board of Directors and the Shareholders China Pharmas, an independent registered public accounting firm, we herebynsent to theorporation by reference in this Registration Statement on Form S-3]

By | 2016-02-07T23:59:12+00:00 December 28th, 2009|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)

[FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): December 18, 2009 SKYSTAR BIO-PHARMACEUTICAL COMPANY Nevada 000-28153 33-0901534 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employer Identification No.) Rm. 10601, Jiezuo Plaza, No.4, Fenghui Road South, Gaoxin District, Xi’an, Shaanxi Province, P.R. China (8629) 8819-3188 (Issuer Telephone Number) N/A (Former name or]

By | 2016-03-01T06:41:08+00:00 December 22nd, 2009|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: FORM 8-K CURRENT REPORT Date of report (Date

[FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): December 18, 2009 SKYSTAR BIO-PHARMACEUTICAL COMPANY Nevada 000-28153 33-0901534 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employer Identification No.) Rm. 10601, Jiezuo Plaza, No.4, Fenghui Road South, Gaoxin District, Xi’an, Shaanxi Province, P.R. China (8629) 8819-3188 (Issuer Telephone Number) N/A (Former name or]

By | 2016-03-01T06:42:04+00:00 December 22nd, 2009|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: (Original Filing)

[FORM 8-K CURRENT REPORTte of report (Date of earliest event reported): December 18, 2009YSTAR BIO-PHARMACEUTICALMPANY Nevada 000-28153 33-0901534 (State or other jurisdiction oforporation or organization) (Commission File No.) (IRS Employer Identification No.) Rm. 10601, Jiezuo Plaza, No.4, Fenghui Road South, Gaoxin District, Xian, Shaanxi Province, P.R. China]

By | 2016-02-05T04:40:35+00:00 December 22nd, 2009|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments
Skip to toolbar